Canertinib dihydrochloride
A potent, irreversible, orally available pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 7.5 nM and 9.0 nM in autophosphorylation assay; displays no activity to PDGFR, FGFR, InsR, PKC, and CDK1/2/4; suppresses heregulin-stimulated tyrosine phosphorylation of erbB2, erbB3 and erbB4 with IC50 of 5, 14 and 10 nM, respectively, also inhibits expression of pp62c-fos in response to heregulin; shows high in vivo activity against A431 xenografts.Lung Cancer Discontinued.
Product Specifications
CAS Number
289499-45-2
Product Name Alternative
Canertinib | CI-1033 dihydrochloride | PD-183805 dihydrochloride | CI1033 dihydrochloride
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
C=CC (=O) NC1=C (C=C2C (=C1) C (=NC=N2) NC3=CC (=C (C=C3) F) Cl) OCCCN4CCOCC4.Cl.Cl
Molecular Formula
C24H27Cl3FN5O3
Molecular Weight
558.8603
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2-Propenamide, N-[4-[ (3-chloro-4-fluorophenyl) amino]-7-[3- (4-morpholinyl) propoxy]-6-quinazolinyl]-, hydrochloride (1:2)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
KRT7 (Keratin 7, CK7, K2C7, K7, MGC129731, MGC3625, SCL, Cytokeratin 7) (MaxLight 750)
KRT7 (Keratin 7, CK7, K2C7, K7, MGC129731, MGC3625, SCL, Cytokeratin 7) (MaxLight 750)
